Table 4 Examples of TEG response to different procoagulant states
From: Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk
| Procoagulant state | Number of patients in study group | TEG version |
Data range in control group,
mean ± SD unless otherwise indicated | Data range in group with hypercoagulation, mean ± SD unless otherwise indicated | Significance | Predictive value | Reference | Comments |
|---|---|---|---|---|---|---|---|---|
| Patients with acute ischemic stroke | 93-Unfavorable outcome evaluatewd by modified Rankin Scale within a year 91-Favorable outcome | Citrate plasma was mixed with kaolin, and loaded in a heparinise-coated cup | means ± SE MA, mm 63.2 ± 0.5 | means ± SE MA, mm 66.1 ± 0.6 | <0.001 | Prediction of unfavorable outcome At higher tertile of MA OR = 1.192 | [92] | Prospective study. |
| Postoperative Thrombotic Complications | 240 patients undergoing a wide variety of surgical procedure s, 10 thrombotic complications | celite-activated TEG on native blood samples within 4 min of collection | MA 66 ± 9 | MA 71 ± 9 | [103] | Prospective study. Thromboelastography was performed immediately after surgery. | ||
| 6 myocardial infarction | MA 66 ± 9 | MA 74 ± 5 | OR = 1.16 | |||||
| Postoperative Thrombotic Complications | 152 critically ill patients in the surgical intensive care unit 16 thrombotic complications | native blood, rTEG(activation with kaolin, human recombinant TF, phospholipids) | G > 12.4 dynes/cm OR = 1.25 | [104] | ||||
| Normal pregnancy | 65/65 | Recalcified citrate plasma | R, min 7.8 ± 2.5 | R, min 6.1 ± 1.8 | <0.001 | [102] | ||
| K, min 2.7 ± 2.3 | K, min 1.4 ± 0.5 | |||||||
| Alfa, deg 57.7 ± 11.6 | Alfa, deg 70.6 ± 6.5 | |||||||
| MA, mm 61 ± 5.9 | MA, mm 71 ± 3.8 | |||||||
| Ly 30, % 0.8 ± 1.7 | Ly 30, % 0.3 ± 0.7 |